Pharma Focus Asia

Navigating IDMP Compliance in the Pharmaceutical Industry

Author: Dr. Marius Schaut, AdEx Partners

Unlocking the Potential of IDMP Compliance 

The IDMP standards, recently boosted by the European Medicines Agency (EMA) with their platform  (Figure 1), aim to facilitate the reliable exchange of medicinal product information worldwide.  Compliance with these standards is not just a regulatory requirement but a strategic move that can  lead to improved patient safety, streamlined operations, and enhanced data management enabling  your organization to see IDMP as a game changer, regardless of the regulatory environment. This can  help position your organization better in several areas by providing a structured framework that  improves communication between stakeholders and thereby enhances patient safety. Additionally, it  can provide a competitive advantage because all departments speak “the same language” when it  comes to data on medicinal products.

Download '.pdf' Format of the whitepaper.

Download Whitepapers
magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024